Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions
NCT06961409 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-05-07
Summary
In order to determine the pathogenesis of chronic inflammatory diseases, the levels of various cytokines are examined in tissues and fluids taken from the body. In recent publications, the role of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF), Macrophage Inflammatory Protein (MIP)-1α and Interleukin (IL)-1β on chronic inflammatory diseases has been investigated. The aim of this study was to evaluate the levels of these cytokines in the saliva of healthy individuals with gingivitis and periodontitis.
All oral clinical parameters of 60 systemically healthy individuals (20 healthy, 20 with gingivitis and 20 with periodontitis) who applied to our clinic for routine periodontal control will be measured and saliva samples will be taken from the patients. GM-CSF, MIP-1α and IL-1β (biomarkers emphasizing inflammation in saliva samples) will be determined by enzyme-linked immunoassay (ELISA). Then, statistical analyses will be performed to interpret the difference in cytokine levels between the groups and the relationship between these cytokines and clinical parameters.
Possible significant differences in cytokine levels will reveal that these proteins and enzymes can be utilized as a diagnostic tool in periodontal diseases, to distinguish periodontal disease status from healthy, or as a guide for treatments.
Conditions
- Periodontal Diseases
- Periodontitis
- Gingivitis
- Periodontal Health
Interventions
- DIAGNOSTIC_TEST
-
Saliva obtaining
The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.
- DIAGNOSTIC_TEST
-
Saliva obtaining
The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.
- DIAGNOSTIC_TEST
-
Saliva obtaining
The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.
Sponsors & Collaborators
-
Izmir Katip Celebi University
lead OTHER
Principal Investigators
-
Şükrü Enhoş, Prof. Dr. · Izmir Katip Celebi University, Faculty of Dentistry, Department of Periodontology
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-14
- Primary Completion
- 2025-08-01
- Completion
- 2025-10-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.
NCT05449093 ·Status: COMPLETED
-
GCF Levels of IL-1Beta, MIP-1 Alfa and G-CSF in Gingivitis and Stage I-II-III-IV Periodontitis Patients
NCT04629313 ·Status: COMPLETED
-
Assessment of Salivary Biomarker Levels in Individuals With Various Periodontal Diseases
NCT07025291 ·Status: COMPLETED ·Phase: NA
-
Comparison of Salivary Biormarkers Levels With Periodontal Clinical Parameters in Smokers and Non-Smokers With Different Periodontal Diseases
NCT06459037 ·Status: COMPLETED ·Phase: NA
-
Chemerin and Interleukin-6 Levels of Gingival Crevicular Fluid in Obese Individuals Following Periodontal Treatment
NCT02660814 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Gingival Crevicular IL-34 and CSF-1 Levels in Patients With Periodontitis and Uncontrolled Type 2 Diabetes
NCT04891627 ·Status: COMPLETED
-
Interleukin-38 Levels in Individuals With Periodontitis
NCT05568290 ·Status: UNKNOWN
-
Gingival Crevicular Fluid (GCF) Bactericidal Permeability Protein (BPI) and Interleukin (IL)-1 Beta
NCT06295666 ·Status: COMPLETED
-
IL-6, IL-17 and IL-35 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls
NCT05306860 ·Status: COMPLETED
-
Evaluation of GCF And Salivary Ferritin, ALP And MMP-8 Levels of Individuals With Different Periodontal Diseases
NCT06561802 ·Status: COMPLETED ·Phase: NA
-
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases
NCT06075680 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Salivary Galectin-8, Galectin-9 and RANKL Levels of Individuals With Different Periodontal Diseases
NCT06404476 ·Status: RECRUITING ·Phase: NA
-
Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment
NCT06354504 ·Status: COMPLETED ·Phase: NA
-
Hepcidin Levels in Periodontal Health and Disease
NCT03789565 ·Status: COMPLETED
-
Evaluation of Salivary Biomarker Levels of Individuals With Different Periodontal Diseases
NCT05774925 ·Status: COMPLETED ·Phase: NA
-
GCF Levels of IL-1β and IL-6 in Gingivitis and Stage III-Grade C Periodontitis
NCT04689438 ·Status: COMPLETED
-
GCF Levels of Chemokines in Periodontitis
NCT06291454 ·Status: COMPLETED
-
IL-10, IL-12 and IL-18 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls
NCT05307068 ·Status: COMPLETED
-
Gingival Crevicular Fluid and Salivary Levels of GDF-15, Smad2, Smad5, Smad6, and IL-6 in Patients With Periodontitis
NCT07201142 ·Status: COMPLETED
-
Gingival Crevicular Fluid, Salivary, and Serum Biomarkers Levels in Periodontal Treatment
NCT05395455 ·Status: COMPLETED ·Phase: NA
-
Microbiome and Proteome Mapping in Periodontitis
NCT06675474 ·Status: COMPLETED
-
Periodontal Disease and Salivary Mitofusin Levels
NCT06510608 ·Status: NOT_YET_RECRUITING
-
Effect of Smoking and Periodontal Therapy on Salivary and Gingival Crevicular IL-17 and IL-35
NCT05281848 ·Status: COMPLETED ·Phase: NA
-
IL-32 Isoforms Levels in GCF and Plasma of the Patients With Periodontitis
NCT04350489 ·Status: COMPLETED
-
IL-32 Levels in Patients With Chronic Periodontitis
NCT02632981 ·Status: COMPLETED ·Phase: PHASE1